ethidium has been researched along with motexafin gadolinium in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angell-Petersen, E; Hirschberg, H; Madsen, SJ; Mathews, MS; Sanchez, R; Sun, CH; Vo, V | 1 |
1 other study(ies) available for ethidium and motexafin gadolinium
| Article | Year |
|---|---|
Motexafin gadolinium enhances the efficacy of aminolevulinic acid mediated-photodynamic therapy in human glioma spheroids.
Topics: Aminolevulinic Acid; Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Dose-Response Relationship, Radiation; Drug Synergism; Ethidium; Glioma; Humans; Metalloporphyrins; Neoplasm Invasiveness; Photochemotherapy; Spheroids, Cellular; Time Factors | 2009 |